ArticleAfrican health sciences2026
Prediabetes and diabetes among patients presenting with acute stroke or acute coronary syndrome at a tertiary regional referral centre in Kenya.
Article in African health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infectious diseases, NCDs, child and reproductive health.African health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes and pre-diabetes are significant risk factors for acute coronary syndrome (ACS) and acute primary stroke (APS). Dysglycemia in any context is under-diagnosed or identified late in resource-poor countries such as in sub-Saharan Africa (SSA), especially when the patient is not known to have pre-morbid diabetes. Materials and methods: We conducted a prospective cross-sectional study at the Aga Khan University Hospital, Nairobi. Inclusion criteria: consenting adults ≥18 years admitted with ACS/APS during the period April 2021-February 2022 inclusive. HbA1C was used to determine the glycemic status. Definition of diabetes and pre-diabetes was based on the American Diabetes Association guidelines. Results: From a total of 211 patients [144 (81.2%) of African race], the median age of the patients was 58 (49-68) years with a male to female ratio of 2.5:1. 47.4% (n = 100) had ACS and 52.6% (n=111) had APS. The prevalence of dysglycemia was 68.2% (95% CI: 61.5%-74.5%) with the prevalence of pre-diabetes being 30.3% (64/211) and type 2 diabetes 37.9% (80/211). Of the patients with dysglycemia, 47.9% (69/144) had a new diagnosis. Conclusion: This study shows a remarkably high prevalence of dysglycemia in patients with ACS/APS. The new diagnosis of pre-diabetes prevalence was comparable to diabetes in these patients, adding to the evidence that prediabetes portends significant cardiometabolic consequences and effects over and above the development of type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.